Enlivex reports positive knee osteoarthritis trial results for Allocetra
Go back to Enlivex reports positive knee osteoarthritis trial results for Allocetra| Enliven Marketing Technologies Corporation (NASDAQ: ENLV) | Delayed: 1.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.25 | 52 Week High | $0.94 | |||
| Open | $1.25 | 52 Week Low | $0.47 | |||
| Day High | $1.25 | P/E | N/A | |||
| Day Low | $1.25 | EPS | $-0.11 | |||
| Volume | 414 | |||||
